Patents by Inventor Peter Gudmund Nielsen

Peter Gudmund Nielsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PULSATILE DRUG DELIVERY SYSTEM FOR TREATING MORNING AKINESIA
    Publication number: 20230078925
    Abstract: Provided herewith is a pharmaceutical composition comprising, separately or together, a pulsatile release component comprising levodopa and a DOPA decarboxylase inhibitor for the management of OFF-time episodes in patients with Parkinson's disease.
    Type: Application
    Filed: September 7, 2022
    Publication date: March 16, 2023
    Inventors: John Bondo HANSEN, Mikael Søndergård THOMSEN, Ann FULLERTON, Bent HØJGAARD, Peter Gudmund NIELSEN
  • Orally available pharmaceutical formulation suitable for improved management of movement disorders
    Patent number: 10561618
    Abstract: The present invention provides a pharmaceutical formulation for oral administration comprising an agonist of two or more of the 5-HT1B, 5-HT1D and 5-HT1F receptors, such as a triptan, e.g. zolmitriptan, in a matrix constituent with extended release characteristics, and further comprising a 5-HT1A-R agonist, such as buspirone, in a constituent with immediate-release characteristics. The special formulation is particularly well-suited for use in the treatment of movement disorders by combining the two active ingredients in a manner that achieves synergy from both the combination per se and the special release parameters of the pharmaceutical formulation, allowing for ease of administration and reducing the risk of adverse effects of each of the two active ingredients.
    Type: Grant
    Filed: April 18, 2013
    Date of Patent: February 18, 2020
    Assignee: Contera Pharma ApS
    Inventors: John Bondo Hansen, Mikael S. Thomsen, Jens D. Mikkelsen, Peter Gudmund Nielsen, Mads Kreilgaard
  • PULSATILE DRUG DELIVERY SYSTEM FOR TREATING MORNING AKINESIA
    Publication number: 20190290587
    Abstract: Provided herewith is a pharmaceutical composition comprising, separately or together, a pulsatile release component comprising levodopa and a DOPA decarboxylase inhibitor for the management of OFF-time episodes in patients with Parkinson's disease.
    Type: Application
    Filed: July 11, 2017
    Publication date: September 26, 2019
    Inventors: John Bondo Hansen, Mikael Søndergård Thomsen, Ann Vivian Fullerton, Bent Højgaard, Peter Gudmund Nielsen
  • ORALLY AVAILABLE PHARMACEUTICAL FORMULATION SUITABLE FOR IMPROVED MANAGEMENT OF MOVEMENT DISORDERS
    Publication number: 20150104506
    Abstract: The present invention provides a pharmaceutical formulation for oral administration comprising an agonist of two or more of the 5-HT1B, 5-HT1D and 5-HT1F receptors, such as a triptan, e.g. zolmitriptan, in a matrix constituent with extended release characteristics, and further comprising a 5-HT1A-R agonist, such as buspirone, in a constituent with immediate-release characteristics. The special formulation is particularly well-suited for use in the treatment of movement disorders by combining the two active ingredients in a manner that achieves synergy from both the combination per se and the special release parameters of the pharmaceutical formulation, allowing for ease of administration and reducing the risk of adverse effects of each of the two active ingredients.
    Type: Application
    Filed: April 18, 2013
    Publication date: April 16, 2015
    Applicant: CONTERA PHARMA APS
    Inventors: John Bondo Hansen, Mikael S. Thomsen, Jens D. Mikkelsen, Peter Gudmund Nielsen, Mads Kreilgaard